Cargando…
Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis
BACKGROUND: The aim of this systematic review and meta-analysis is to assess effectiveness and safety of Chinese medicine (CM) as complementary therapy in treating coronavirus disease 2019 (COVID-19). METHODS: The following databases will be searched: PubMed, Cochrane, Embase, China National Knowled...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437844/ https://www.ncbi.nlm.nih.gov/pubmed/32871977 http://dx.doi.org/10.1097/MD.0000000000021034 |
_version_ | 1783572700802842624 |
---|---|
author | Zhou, Min Liang, Qijun Pei, QiuLan Xu, Fan Wen, Hang |
author_facet | Zhou, Min Liang, Qijun Pei, QiuLan Xu, Fan Wen, Hang |
author_sort | Zhou, Min |
collection | PubMed |
description | BACKGROUND: The aim of this systematic review and meta-analysis is to assess effectiveness and safety of Chinese medicine (CM) as complementary therapy in treating coronavirus disease 2019 (COVID-19). METHODS: The following databases will be searched: PubMed, Cochrane, Embase, China National Knowledge Infrastructure, Chinese Science and Technology Periodical Database, and Wanfang database from October 1, 2019 to March 1, 2020. Randomized trials and quasi-randomized or prospective controlled clinical trials of CM that reported data on COVID-19 patients will be included. Study selection, data extraction, quality assessment, and assessment of risk bias will be performed by 2 reviewers independently. Odds ratios and correlative 95% confidence intervals will be calculated to present the association between the CM and CWM using Review Manager version 5.3 when there is sufficient available data. RESULTS: The results will be disseminated through a peer-reviewed journal publication. CONCLUSION: This systematic review findings will summarize up-to-date evidence for that CM is more effective and safe as adjunctive treatment for patients with COVID-19. ETHICS AND DISSEMINATION: Ethics approval and patient consent are not required as this study is a systematic review based on published articles. PROSPERO REGISTRATION NUMBER: CRD42020185382. |
format | Online Article Text |
id | pubmed-7437844 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-74378442020-09-02 Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis Zhou, Min Liang, Qijun Pei, QiuLan Xu, Fan Wen, Hang Medicine (Baltimore) 6600 BACKGROUND: The aim of this systematic review and meta-analysis is to assess effectiveness and safety of Chinese medicine (CM) as complementary therapy in treating coronavirus disease 2019 (COVID-19). METHODS: The following databases will be searched: PubMed, Cochrane, Embase, China National Knowledge Infrastructure, Chinese Science and Technology Periodical Database, and Wanfang database from October 1, 2019 to March 1, 2020. Randomized trials and quasi-randomized or prospective controlled clinical trials of CM that reported data on COVID-19 patients will be included. Study selection, data extraction, quality assessment, and assessment of risk bias will be performed by 2 reviewers independently. Odds ratios and correlative 95% confidence intervals will be calculated to present the association between the CM and CWM using Review Manager version 5.3 when there is sufficient available data. RESULTS: The results will be disseminated through a peer-reviewed journal publication. CONCLUSION: This systematic review findings will summarize up-to-date evidence for that CM is more effective and safe as adjunctive treatment for patients with COVID-19. ETHICS AND DISSEMINATION: Ethics approval and patient consent are not required as this study is a systematic review based on published articles. PROSPERO REGISTRATION NUMBER: CRD42020185382. Lippincott Williams & Wilkins 2020-08-14 /pmc/articles/PMC7437844/ /pubmed/32871977 http://dx.doi.org/10.1097/MD.0000000000021034 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections. |
spellingShingle | 6600 Zhou, Min Liang, Qijun Pei, QiuLan Xu, Fan Wen, Hang Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis |
title | Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis |
title_full | Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis |
title_fullStr | Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis |
title_full_unstemmed | Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis |
title_short | Chinese medicine for coronavirus disease 2019 as complementary therapy: A protocol for a systematic review and meta-analysis |
title_sort | chinese medicine for coronavirus disease 2019 as complementary therapy: a protocol for a systematic review and meta-analysis |
topic | 6600 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7437844/ https://www.ncbi.nlm.nih.gov/pubmed/32871977 http://dx.doi.org/10.1097/MD.0000000000021034 |
work_keys_str_mv | AT zhoumin chinesemedicineforcoronavirusdisease2019ascomplementarytherapyaprotocolforasystematicreviewandmetaanalysis AT liangqijun chinesemedicineforcoronavirusdisease2019ascomplementarytherapyaprotocolforasystematicreviewandmetaanalysis AT peiqiulan chinesemedicineforcoronavirusdisease2019ascomplementarytherapyaprotocolforasystematicreviewandmetaanalysis AT xufan chinesemedicineforcoronavirusdisease2019ascomplementarytherapyaprotocolforasystematicreviewandmetaanalysis AT wenhang chinesemedicineforcoronavirusdisease2019ascomplementarytherapyaprotocolforasystematicreviewandmetaanalysis |